Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration
Open Access
- 19 June 2014
- journal article
- research article
- Published by Springer Nature in Diagnostic Pathology
- Vol. 9 (1) , 123
Abstract
Bone morphogenetic protein 2 (BMP-2) is a member of the TGF-β superfamily that is closely correlated with many malignancies, particularly lung cancer. However, the effects of silenced BMP-2 on lung cancer cell proliferation and migration are not clear.Keywords
This publication has 32 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Bone Morphogenetic Proteins and CancerNeurosurgery, 2010
- BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathwayExperimental Cell Research, 2010
- Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathwayOncogene, 2008
- Bone Morphogenetic Protein-2–Induced Transformation Involves the Activation of Mammalian Target of RapamycinMolecular Cancer Research, 2005
- Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1/5Oncogene, 2005
- Expression of Bone Morphogenetic Proteins in Human Lung CarcinomasThe Annals of Thoracic Surgery, 2005
- The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cellsCarcinogenesis, 2003
- Focus on lung cancerCancer Cell, 2002
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988